Evolent Health, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2023 and for the Year Ending December 31, 2023
For the year ending, the revenue expected to be in the range of approximately $1.935 billion to $1.965 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.55 USD | -1.26% | -13.71% | -28.76% |
1st Jan change | Capi. | |
---|---|---|
-28.76% | 2.74B | |
+9.61% | 32.94B | |
+21.53% | 7.83B | |
+36.69% | 4.26B | |
-19.56% | 1.39B | |
-28.50% | 1.27B | |
-32.48% | 1.17B | |
+13.47% | 988M | |
-37.86% | 884M | |
-26.68% | 726M |